Hello!
We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
09.06.2023
Offline
Stockholm, Sweden, 8 June 2023 - MGI Tech Co. Ltd. ("MGI"), a global leader in life science technology, is thrilled to announce a strategic collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment. This partnership aims to significantly enhance the distribution of MGI's cutting-edge products* in the Nordic region, leveraging the expertise and market presence of AddLife AB's Triolab Group subsidiaries, and expanding into innovative fields such as point-of-care testing (POCT) and remote ultrasound.
Under the agreement, AddLife AB's four Triolab Group subsidiaries, namely Triolab Sweden, Triolab Norway, Triolab Denmark (Iceland), and Triolab Finland will serve as separate distributors for MGI's innovative products*. This partnership represents a significant milestone in the life science industry, combining the strengths of two industry leaders to meet the evolving needs of healthcare providers in the Nordic region.
"At AddLife, we aim to meet all our customers' needs at the highest level. Innovation is one of our core values and the addition of the product line from MGI is a perfect complement to our laboratory portfolio in that respect. It gives our customers the possibility to use the most modern and innovative technology.", Kai Rantanen, Head of the Diagnostic Business at AddLife AB said.
Duncan Yu, President of MGI, also shared his thoughts on the collaboration, stating, "We are thrilled to partner with AddLife AB and its Triolab Group subsidiaries to expand our reach in the Nordic region. The extensive distribution network and market expertise of AddLife AB, combined with MGI's leading-edge sequencing products*, will enable us to effectively meet the needs of healthcare professionals and contribute to improved patient outcomes.”
The collaboration between MGI and AddLife AB represents a significant milestone in responding to the evolving needs of healthcare providers in the Nordic region. By combining their respective strengths and expertise, both companies aim to accelerate the adoption of cutting-edge sequencing technologies and promote improved patient care across the region.
AddLife is an independent European provider in life science that offers high quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 85 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 9 billion. AddLife is listed on the Nasdaq Stockholm stock exchange.